SAGE — Sage Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Sage Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,100	1,742	1,272	753	504
Net Total Accounts Receivable
Net Total Receivables	—	18.5	13.7	88.6	12.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,122	1,801	1,337	869	531
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.8	19.1	13.4	6.38	11.6
Other Long Term Assets
Total Assets	2,159	1,825	1,356	882	547
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	67.2	85.2	99.3	82.7	71.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	86.9	96.3	104	82.7	82.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,072	1,729	1,253	800	465
Total Liabilities & Shareholders' Equity	2,159	1,825	1,356	882	547
Total Common Shares Outstanding